Cargando…

The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition

Mostrar otras versiones (1)

The COVID-19 pandemic remains a global threat, and host immunity remains the main mechanism of protection against the disease. The spike protein on the surface of SARS-CoV-2 is a major antigen and its engagement with human ACE2 receptor plays an essential role in viral entry into host cells. Consequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattori, Takamitsu, Koide, Akiko, Panchenko, Tatyana, Romero, Larizbeth A., Teng, Kai Wen, Tada, Takuya, Landau, Nathaniel R., Koide, Shohei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654858/ https://www.ncbi.nlm.nih.gov/pubmed/33173869 http://dx.doi.org/10.1101/2020.11.03.365270

Ejemplares similares

The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition
por: Hattori, Takamitsu, et al.
Publicado: (2021)

Multiplex bead binding assays using off-the-shelf components and common flow cytometers
por: Hattori, Takamitsu, et al.
Publicado: (2021)

Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
por: Noval, Maria G., et al.
Publicado: (2021)

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
por: Koide, Akiko, et al.
Publicado: (2021)

Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions
por: Christie, Shaun M., et al.
Publicado: (2022)

Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023)

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
por: Oury, Julien, et al.
Publicado: (2021)

Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
por: Hattori, Takamitsu, et al.
Publicado: (2023)

Selective and noncovalent targeting of RAS mutants for inhibition and degradation
por: Teng, Kai Wen, et al.
Publicado: (2021)

Archaeal chromatin ‘slinkies’ are inherently dynamic complexes with deflected DNA wrapping pathways
por: Bowerman, Samuel, et al.
Publicado: (2021)

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
por: Grebien, Florian, et al.
Publicado: (2011)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

Proof of dual-topology architecture of Fluc F(-) channels with monobody blockers
por: Stockbridge, Randy B., et al.
Publicado: (2014)

Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors
por: Akkapeddi, Padma, et al.
Publicado: (2023)

Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
por: Rizk, Shahir S., et al.
Publicado: (2017)

An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
por: Tada, Takuya, et al.
Publicado: (2020)

Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket
por: Wallon, Lauren, et al.
Publicado: (2022)

Zn(2+) and Cu(2+) Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein
por: Pelucelli, Alessio, et al.
Publicado: (2023)

Atomic structure of the eukaryotic intramembrane Ras methyltransferase ICMT
por: Diver, Melinda M., et al.
Publicado: (2018)

Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies
por: Kükenshöner, Tim, et al.
Publicado: (2017)

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
por: Bugatti, Kelly, et al.
Publicado: (2023)

Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex
por: Miotto, Mattia, et al.
Publicado: (2023)

Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
por: Tada, Takuya, et al.
Publicado: (2023)

Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)
por: Kaur, Ramanjit, et al.
Publicado: (2023)

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
por: Dokainish, Hisham M, et al.
Publicado: (2022)

Renewable, recombinant antibodies to histone post-translational modifications
por: Hattori, Takamitsu, et al.
Publicado: (2013)

ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation
por: Nady, Nataliya, et al.
Publicado: (2015)

Zinc binding alters the conformational dynamics and drives the transport cycle of the cation diffusion facilitator YiiP
por: Lopez-Redondo, Maria, et al.
Publicado: (2021)

SHP2 inhibition diminishes KRAS(G12C) cycling and promotes tumor microenvironment remodeling
por: Fedele, Carmine, et al.
Publicado: (2020)

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
por: Wojcik, John, et al.
Publicado: (2010)

Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
por: Zhou, Hao, et al.
Publicado: (2022)

Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
por: Ali, Amanat, et al.
Publicado: (2020)

Monobodies as tool biologics for accelerating target validation and druggable site discovery
por: Akkapeddi, Padma, et al.
Publicado: (2021)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Crystal structures of a double-barrelled fluoride ion channel
por: Stockbridge, Randy B., et al.
Publicado: (2015)

sNASP and ASF1A function through both competitive and compatible modes of histone binding
por: Bowman, Andrew, et al.
Publicado: (2017)

Crystal structures of bacterial small multidrug resistance transporter EmrE in complex with structurally diverse substrates
por: Kermani, Ali A, et al.
Publicado: (2022)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
por: Semenov, Valentin A., et al.
Publicado: (2022)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2rbq7ccunk1na9qq197vlgdncd